Modi Naturals approves auditor appointments at 52nd AGM

2 min read     Updated on 01 Aug 2026, 12:59 PM
scanx
Reviewed by
Shriram SScanX News Team
AI Summary

Modi Naturals Limited concluded its 52nd AGM on July 31, 2026, with shareholders approving the adoption of FY26 financial statements, the re-appointment of Director Mrs. Aditi Modi, and the five-year tenure of new statutory and secretarial auditors. The virtual meeting saw participation from 120 members, with clean audit reports confirming robust governance practices.

powered bylight_fuzz_icon
47114945

*this image is generated using AI for illustrative purposes only.

Shareholders of Modi Naturals Limited approved key governance resolutions, including the appointment of new statutory and secretarial auditors, during the company's 52nd Annual General Meeting (AGM) held on July 31, 2026. The meeting, conducted via Video Conferencing (VC) or Other Audio-Visual Means (OAVM), addressed critical compliance matters under Regulation 30 read with Schedule III - Para A of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

The proceedings were chaired by Akshay Modi, who took the chair in the absence of Anil Modi due to ill health. One hundred twenty members joined the virtual meeting, which commenced at 2:30 p.m. IST and concluded at 3:13 p.m. IST. The quorum was present throughout, allowing for the transacting of all business items listed in the notice dated July 6, 2026.

Key Resolutions Passed

The shareholders voted on six ordinary resolutions covering both ordinary and special business items. The most significant outcomes included the regularization and five-year appointment of M/s B. Chhawcharia & Co. as Statutory Auditors to fill a casual vacancy, and the appointment of M/s A.K. Verma & Co. as Secretarial Auditors for a term of five consecutive years.

Resolution Item Type Outcome
Adoption of FY26 Financial Statements Ordinary Passed
Re-appointment of Mrs. Aditi Modi as Director Ordinary Passed
Appointment of Statutory Auditors (5-year term) Ordinary Passed
Appointment of Secretarial Auditors (5-year term) Ordinary Passed
Ratification of Cost Auditor Remuneration Ordinary Passed

Mrs. Aditi Modi, who was retiring by rotation, was successfully re-appointed as a Director. Additionally, the board sought ratification for the remuneration payable to Cost Auditors for the financial year 2026-27.

Governance and Compliance Details

The Company Secretary, Rajan Kumar Singh, confirmed that the reports from the Statutory Auditors, M/s Doogar & Associates Chartered Accountants, and the Secretarial Auditor, M/s Deepak Bansal & Associates, contained no qualifications, reservations, or adverse remarks. These reports were taken as read with member consent.

Remote e-voting was conducted from July 28, 2026, at 10:00 a.m. IST to July 30, 2026, at 5:00 p.m. IST. Shareholders holding shares as of the cut-off date of July 24, 2026, were eligible to vote. The consolidated voting results are scheduled to be announced within two working days and submitted to BSE Limited and the National Stock Exchange of India Limited.

What the Numbers Show

The clean audit reports from both statutory and secretarial auditors indicate strong internal controls and regulatory compliance for Modi Naturals Limited in FY26. The successful re-appointment of long-term auditors suggests stability in the company's financial reporting framework, providing investors with confidence in the accuracy of the adopted standalone and consolidated financial statements.

Historical Stock Returns for Modi Naturals

1 Day5 Days1 Month6 Months1 Year5 Years
-2.04%-6.91%-11.70%+14.03%+2.54%+2.54%

How might the five-year tenure of the newly appointed statutory and secretarial auditors impact Modi Naturals' long-term financial transparency and investor confidence?

What strategic initiatives is Mrs. Aditi Modi expected to prioritize during her re-appointed term as Director?

Will the clean audit reports for FY26 lead to an upgrade in the company's credit rating or improved terms with financial institutions?

Modi Naturals appoints Ankita Singal as independent director at subsidiary

1 min read     Updated on 30 Jul 2026, 09:40 PM
scanx
Reviewed by
Jubin VScanX News Team
AI Summary

Modi Naturals Limited appointed Ankita Singal as an independent director at its subsidiary Modi Biotech Private Limited on July 30, 2026. The appointment follows approval at the subsidiary's AGM and complies with SEBI Listing Regulations. Singal brings two decades of experience in finance and business management to the board.

powered bylight_fuzz_icon
46973416

*this image is generated using AI for illustrative purposes only.

Modi Naturals Limited has appointed Ankita Singal as a Non-Executive Independent Women Director at its unlisted material subsidiary, Modi Biotech Private Limited. The appointment was approved by the members of Modi Biotech at their fifth Annual General Meeting held on July 30, 2026, and becomes effective on the same date. This move strengthens the governance framework of the subsidiary, ensuring compliance with regulatory requirements for independent representation on the board.

The disclosure was made in compliance with Regulation 24 and Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. Additionally, the company adhered to SEBI Circular No. SEBI/HO/CFD/PoD2/CIR/P/0155 dated November 11, 2024, regarding disclosures related to changes in directorship. Rajan Kumar Singh, Company Secretary & Compliance Officer of Modi Naturals Limited, signed the intimation letter submitted to both the Bombay Stock Exchange (BSE) and the National Stock Exchange of India Limited (NSE).

Appointment Details

The key details of the appointment are outlined below:

Particulars Details
Appointee Ankita Singal (DIN: 01633449)
Role Non-Executive Independent Women Director
Entity Modi Biotech Private Limited
Effective Date July 30, 2026
Approval Forum 5th Annual General Meeting of Modi Biotech

Profile and Compliance

Ankita Singal holds a Bachelor of Commerce (Honours) degree from Lady Shriram College for Women, Delhi University, and a Master in Business Administration from Infinity Business School. She possesses approximately 20 years of experience across finance, marketing, and general business management.

As per the disclosure requirements under BSE Circular No. LIST/COMP/14/2018-19 dated June 20, 2018, and NSE Circular No. NSE/CML/2018/02 dated June 20, 2018, Singal is not related to any existing directors of Modi Naturals Limited. Furthermore, she is not debarred from holding the office of a Director by virtue of any order issued by the Ministry of Corporate Affairs (MCA), SEBI, or any other statutory authority.

Historical Stock Returns for Modi Naturals

1 Day5 Days1 Month6 Months1 Year5 Years
-2.04%-6.91%-11.70%+14.03%+2.54%+2.54%

How might Ankita Singal's 20 years of experience in finance and marketing influence Modi Biotech's strategic growth plans for its unlisted operations?

Does this appointment signal a broader initiative by Modi Naturals to enhance corporate governance across its subsidiary portfolio ahead of potential future listing requirements?

What specific regulatory or operational challenges within the biotech sector is Modi Biotech aiming to address by strengthening its independent board representation?

More News on Modi Naturals

1 Year Returns:+2.54%